{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:26:00Z","timestamp":1786994760683,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research Affairs","award":["15730-7"],"award-info":[{"award-number":["15730-7"]}]},{"name":"Shahid Beheshti University of Medical Sciences, Iran"},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation (INSF)","doi-asserted-by":"publisher","award":["96017110"],"award-info":[{"award-number":["96017110"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.neulet.2019.03.033","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T13:10:03Z","timestamp":1553087403000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Enhancing the expression of neurotrophic factors in epidermal neural crest stem cells by valproic acid: A potential candidate for combinatorial treatment"],"prefix":"10.1016","volume":"704","author":[{"given":"Sareh","family":"Pandamooz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Saied","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8272-291X","authenticated-orcid":false,"given":"Anahid","family":"Safari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Azarpira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansooreh","family":"Heravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolhassan","family":"Ahmadiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7777-5435","authenticated-orcid":false,"given":"Leila","family":"Dargahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2019.03.033_bib0005","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1172\/JCI42957","article-title":"Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury","volume":"120","author":"Abematsu","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2019.03.033_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pharmthera.2013.01.004","article-title":"GDNF, NGF and BDNF as therapeutic options for neurodegeneration","volume":"138","author":"Allen","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neulet.2019.03.033_bib0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bcpt.12201","article-title":"Induction of neurotrophic and differentiation factors in neural stem cells by valproic acid","volume":"115","author":"Almutawaa","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neulet.2019.03.033_bib0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0074-7742(02)50083-0","article-title":"Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?","volume":"50","author":"Apfel","year":"2002","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neulet.2019.03.033_bib0025","doi-asserted-by":"crossref","first-page":"10535","DOI":"10.1523\/JNEUROSCI.1903-07.2007","article-title":"Transient growth factor delivery sustains regenerated axons after spinal cord injury","volume":"27","author":"Blesch","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2019.03.033_bib0030","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","article-title":"Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes","volume":"11","author":"Chen","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2019.03.033_bib0035","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s11064-014-1241-2","article-title":"Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries","volume":"39","author":"Chen","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2019.03.033_bib0040","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/14712598.2016.1183641","article-title":"Engineered BDNF producing cells as a potential treatment for neurologic disease","volume":"16","author":"Deng","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.neulet.2019.03.033_bib0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbr.2010.05.023","article-title":"Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington\u2019s disease","volume":"214","author":"Dey","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neulet.2019.03.033_bib0050","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5966\/sctm.2013-0129","article-title":"Canine epidermal neural crest stem cells: characterization and potential as therapy candidate for a large animal model of spinal cord injury","volume":"3","author":"Gericota","year":"2014","journal-title":"Stem Cell Transl. Med."},{"key":"10.1016\/j.neulet.2019.03.033_bib0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2014.10.049","article-title":"Neurotrophic factors for spinal cord repair: which, where, how and when to apply, and for what period of time?","volume":"1619","author":"Harvey","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2019.03.033_bib0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12015-010-9152-3","article-title":"Epidermal neural crest stem cell (EPI-NCSC)\u2014mediated recovery of sensory function in a mouse model of spinal cord injury","volume":"6","author":"Hu","year":"2010","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.neulet.2019.03.033_bib0065","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson\u2019s disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.03.033_bib0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputamenal glial cell line\u2013derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2019.03.033_bib0075","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","article-title":"Gene delivery of AAV2-neurturin for Parkinson\u2019s disease: a double-blind, randomised, controlled trial","volume":"9","author":"Marks","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2019.03.033_bib0080","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1474-4422(08)70065-6","article-title":"Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2\u2013neurturin) to patients with idiopathic Parkinson\u2019s disease: an open-label, phase I trial","volume":"7","author":"Marks","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neulet.2019.03.033_bib0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuint.2017.02.006","article-title":"Neural stem cell therapy for neurodegenerative disorders: the role of neurotrophic support","volume":"106","author":"Marsh","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2019.03.033_bib0090","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5966\/sctm.2012-0147","article-title":"Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play","volume":"2","author":"Neirinckx","year":"2013","journal-title":"Stem Cell Transl. Med."},{"key":"10.1016\/j.neulet.2019.03.033_bib0095","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1017\/S1461145711001969","article-title":"Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain","volume":"15","author":"Niles","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2019.03.033_bib0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14660820050515197","article-title":"A phase I\/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis","volume":"1","author":"Ochs","year":"2000","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"10.1016\/j.neulet.2019.03.033_bib0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2176\/nmc.52.186","article-title":"Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain","volume":"52","author":"Osuka","year":"2012","journal-title":"Neurol. Med. Chir."},{"key":"10.1016\/j.neulet.2019.03.033_bib0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/scrt235","article-title":"The influence of cerebrospinal fluid on epidermal neural crest stem cells may pave the path for cell-based therapy","volume":"4","author":"Pandamooz","year":"2013","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.neulet.2019.03.033_bib0115","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1002\/jcb.26520","article-title":"Epidermal neural crest stem cell\u2010derived glia enhance neurotrophic elements in an ex vivo model of spinal cord injury","volume":"119","author":"Pandamooz","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.neulet.2019.03.033_bib0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn3379","article-title":"Poo, Neurotrophin regulation of neural circuit development and function","volume":"14","author":"Park","year":"2013","journal-title":"Nature Rev. Neurosci."},{"key":"10.1016\/j.neulet.2019.03.033_bib0125","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/mt.2016.12","article-title":"Human mesenchymal stem cells genetically engineered to overexpress brain-derived neurotrophic factor improve outcomes in Huntington\u2019s disease mouse models","volume":"24","author":"Pollock","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neulet.2019.03.033_bib0130","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1471-4159.2005.03457.x","article-title":"Novel targets for valproic acid: up\u2010regulation of melatonin receptors and neurotrophic factors in C6 glioma cells","volume":"95","author":"Rinc\u00f3n Castro","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2019.03.033_bib0135","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1126\/science.3201248","article-title":"Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression","volume":"242","author":"Rosenberg","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.neulet.2019.03.033_bib0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s12015-008-9042-0","article-title":"Epidermal neural crest stem cells (EPI-NCSC) and pluripotency","volume":"4","author":"Sieber-Blum","year":"2008","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.neulet.2019.03.033_bib0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/bdrc.20008","article-title":"The adult hair follicle: cradle for pluripotent neural crest stem cells","volume":"72","author":"Sieber\u2010Blum","year":"2004","journal-title":"Birth Defects Res. C. Embryo Today Rev."},{"key":"10.1016\/j.neulet.2019.03.033_bib0150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-4886(03)00394-7","article-title":"Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration","volume":"184","author":"Tobias","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2019.03.033_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.09.007","article-title":"Treatment of spinal cord injury by an advanced cell transplantation technology using brain-derived neurotrophic factor-transfected mesenchymal stem cell spheroids","volume":"109","author":"Uchida","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.neulet.2019.03.033_bib0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.24436","article-title":"Gene delivery of neurturin to putamen and substantia nigra in P arkinson disease: A double-blind, randomized, controlled trial","volume":"78","author":"Warren Olanow","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2019.03.033_bib0165","doi-asserted-by":"crossref","first-page":"27358","DOI":"10.1038\/srep27358","article-title":"Gain of BDNF function in engrafted neural stem cells promotes the therapeutic potential for Alzheimer\u2019s disease","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neulet.2019.03.033_bib0170","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S1461145708009024","article-title":"Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons","volume":"11","author":"Wu","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2019.03.033_bib0175","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s12094-016-1494-0","article-title":"Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1\u03b1\/VEGF signals","volume":"18","author":"Zhao","year":"2016","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.neulet.2019.03.033_bib0180","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nature Rev. Neurol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019301958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394019301958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T00:40:05Z","timestamp":1569026405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394019301958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":36,"alternative-id":["S0304394019301958"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2019.03.033","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing the expression of neurotrophic factors in epidermal neural crest stem cells by valproic acid: A potential candidate for combinatorial treatment","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2019.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}